J. Michael Redmond serves as Executive at BIOJECT MEDICAL TECHNOLOGIES INC, where they oversee executive responsibilities. Since joining the company, J. Michael Redmond has executed 11 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 2, 2022 involved gifting 1,500,000 shares valued at $240.0K.
J. Michael Redmond currently holds 8,500,000 shares of BIOJECT MEDICAL TECHNOLOGIES INC (BJCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, J. Michael Redmond has been a net neutral trader of BJCT stock. They have purchased $0 and sold $0 worth of shares.
J. Michael Redmond's most recent insider trade was on Sep 2, 2022, when they sold 1,500,000 shares at $0.16 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 1, 2007 | BJCT | $43.2K | Payment | 32,702 | $1.32 | Discretionary |
| Mar 10, 2007 | BJCT | $0 | Option Exercise | 10,000 | $N/A | Discretionary |
| Mar 10, 2007 | BJCT | $3.2K | Payment | 2,500 | $1.28 | Discretionary |
| Jan 28, 2007 | BJCT | $1.8K | Payment | 1,630 | $1.10 | Discretionary |
| Jan 28, 2007 | BJCT | $0 | Option Exercise | 6,520 | $N/A | Discretionary |
| Jan 19, 2007 | BJCT | $0 | Award | 1,717 | $N/A | Discretionary |
| Dec 8, 2006 | BJCT | $0 | Option Exercise | 2,575 | $N/A | Discretionary |
| Dec 8, 2006 | BJCT | $701 | Payment | 643 | $1.09 | Discretionary |
| Mar 23, 2006 | BJCT | $31.7K | Conversion | 18,840 | $1.68 | Discretionary |